Ben-Ari Y - Search Results

1

Holmes GL, Khazipov R, Ben-Ari Y. Holmes GL, et al. Neuroreport. 2002 Jan 21;13(1):A3-8. doi: 10.1097/00001756-200201210-00002. Neuroreport. 2002. PMID: 11924904 Review.

2

Seizure-induced damage in the developing human: relevance of experimental models.

Holmes GL, Khazipov R, Ben-Ari Y. Holmes GL, et al. Prog Brain Res. 2002;135:321-34. doi: 10.1016/S0079-6123(02)35030-1. Prog Brain Res. 2002. PMID: 12143352 Review.

3

Timing of the developmental switch in GABA(A) mediated signaling from excitation to inhibition in CA3 rat hippocampus using gramicidin perforated patch and extracellular recordings.

Tyzio R, Holmes GL, Ben-Ari Y, Khazipov R. Tyzio R, et al. Epilepsia. 2007;48 Suppl 5:96-105. doi: 10.1111/j.1528-1167.2007.01295.x. Epilepsia. 2007. PMID: 17910587 Free article.

4

Membrane potential of CA3 hippocampal pyramidal cells during postnatal development.

Tyzio R, Ivanov A, Bernard C, Holmes GL, Ben-Ari Y, Khazipov R. Tyzio R, et al. J Neurophysiol. 2003 Nov;90(5):2964-72. doi: 10.1152/jn.00172.2003. Epub 2003 Jul 16. J Neurophysiol. 2003. PMID: 12867526 Free article.

5

Postnatal changes in somatic gamma-aminobutyric acid signalling in the rat hippocampus.

Tyzio R, Minlebaev M, Rheims S, Ivanov A, Jorquera I, Holmes GL, Zilberter Y, Ben-Ari Y, Khazipov R. Tyzio R, et al. Eur J Neurosci. 2008 May;27(10):2515-28. doi: 10.1111/j.1460-9568.2008.06234.x. Eur J Neurosci. 2008. PMID: 18547241

6

NMDA receptors pattern early activity in the developing barrel cortex in vivo.

Minlebaev M, Ben-Ari Y, Khazipov R. Minlebaev M, et al. Cereb Cortex. 2009 Mar;19(3):688-96. doi: 10.1093/cercor/bhn115. Epub 2008 Jul 28. Cereb Cortex. 2009. PMID: 18663251

7

Temporal coding at the immature depolarizing GABAergic synapse.

Valeeva G, Abdullin A, Tyzio R, Skorinkin A, Nikolski E, Ben-Ari Y, Khazipov R. Valeeva G, et al. Front Cell Neurosci. 2010 Jul 14;4:17. doi: 10.3389/fncel.2010.00017. eCollection 2010. Front Cell Neurosci. 2010. PMID: 20725525 Free PMC article.

8

A Double-Blind, Randomized, Placebo-Controlled Trial of Bumetanide in Parkinson's Disease.

Damier P, Degos B, Castelonovo G, Anheim M, Benatru I, Carrière N, Colin O, Defebvre L, Deverdal M, Eusebio A, Ferrier V, Giordana C, Houeto JL, Le Dily S, Mongin M, Thiriez C, Tranchant C, Ravel D, Corvol JC, Rascol O, Ben Ari Y. Damier P, et al. Among authors: ben ari y. Mov Disord. 2024 Mar;39(3):618-622. doi: 10.1002/mds.29726. Epub 2024 Jan 30. Mov Disord. 2024. PMID: 38291616 Clinical Trial.

9

Bumetanide oral solution for the treatment of children and adolescents with autism spectrum disorder: Results from two randomized phase III studies.

Fuentes J, Parellada M, Georgoula C, Oliveira G, Marret S, Crutel V, Albarran C, Lambert E, Pénélaud PF, Ravel D, Ben Ari Y. Fuentes J, et al. Among authors: ben ari y. Autism Res. 2023 Oct;16(10):2021-2034. doi: 10.1002/aur.3005. Epub 2023 Oct 4. Autism Res. 2023. PMID: 37794745 Clinical Trial.

10

GABA Signaling: Therapeutic Targets for Neurodegenerative and Neurodevelopmental Disorders.

Cherubini E, Ben-Ari Y. Cherubini E, et al. Among authors: ben ari y. Brain Sci. 2023 Aug 25;13(9):1240. doi: 10.3390/brainsci13091240. Brain Sci. 2023. PMID: 37759841 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

550 results

Search Page